A pathogen type III effector with a novel E3 ubiquitin ligase architecture.
Type III effectors are virulence factors of Gram-negative bacterial pathogens delivered directly into host cells by the type III secretion nanomachine where they manipulate host cell processes such as the innate immunity and gene expression. Here, we show that the novel type III effector XopL from t...
Guardado en:
Autores principales: | Alexander U Singer, Sebastian Schulze, Tatiana Skarina, Xiaohui Xu, Hong Cui, Lennart Eschen-Lippold, Monique Egler, Tharan Srikumar, Brian Raught, Justin Lee, Dierk Scheel, Alexei Savchenko, Ulla Bonas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4aad9687058448118ec2d3202dbc7729 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NleG Type 3 effectors from enterohaemorrhagic Escherichia coli are U-Box E3 ubiquitin ligases.
por: Bin Wu, et al.
Publicado: (2010) -
A 1-phytase type III effector interferes with plant hormone signaling
por: Doreen Blüher, et al.
Publicado: (2017) -
Structural Diversity of Ubiquitin E3 Ligase
por: Sachiko Toma-Fukai, et al.
Publicado: (2021) -
A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence.
por: Chris Boutell, et al.
Publicado: (2011) -
The ubiquitin ligase ZNRF1 promotes caveolin-1 ubiquitination and degradation to modulate inflammation
por: Chih-Yuan Lee, et al.
Publicado: (2017)